Search - tctmd.com

Displaying 321 - 340 of 806

Sort: Relevancy | Date

Half-Dose DOAC May Be a Good Post-Watchman Option

News Daily News

Half-Dose DOAC May Be a Good Post-Watchman Option

October 14, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

COVID-19: TCTMD’s Dispatch for October Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 2

October 11, 2021

Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines

News Daily News

Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines

October 06, 2021

COVID-19: TCTMD’s Dispatch for October Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 1

October 04, 2021

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

News Features

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

September 28, 2021

FDA Investigating Possible Sex Differences in LAAO Outcomes

News Daily News

FDA Investigating Possible Sex Differences in LAAO Outcomes

September 27, 2021

COVID-19: TCTMD’s Dispatch for September Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for September Week 5

September 27, 2021

Score May Help Guide VITT Management After COVID-19 Vaccination

News Daily News

Score May Help Guide VITT Management After COVID-19 Vaccination

September 23, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 4

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 4

September 20, 2021

Renal Denervation a Third Option for Hypertension, European Experts Say

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

September 17, 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

News Conference News HFSA 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

September 13, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 3

September 13, 2021

Compensation in 2020 Survived COVID-19, CV Professionals Say

News Daily News

Compensation in 2020 Survived COVID-19, CV Professionals Say

September 10, 2021

Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes

News Daily News

Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes

September 09, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 2

September 08, 2021

Biomarker Levels ID Patients With Most to Gain From Intensive BP Lowering

News Daily News

Biomarker Levels ID Patients With Most to Gain From Intensive BP Lowering

September 08, 2021

STEP Trial Supports Lower BP Goal in Older Patients With Hypertension

News Conference News ESC 2021

STEP Trial Supports Lower BP Goal in Older Patients With Hypertension

August 30, 2021

COVID-19: TCTMD’s Daily Dispatch for September Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September Week 1

August 30, 2021

Number of People With Hypertension Doubles Since 1990

News Daily News

Number of People With Hypertension Doubles Since 1990

August 26, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.